Recurrent and novel SS18-SSX fusion transcripts in synovial sarcoma: description of three new cases
Open Access
- 14 September 2012
- journal article
- research article
- Published by Springer Nature in Tumor Biology
- Vol. 33 (6) , 2245-2253
Abstract
Synovial sarcoma (SS) is an aggressive type of tumor, comprising approximately 10 % of soft tissue sarcomas. Over 90 % of SS cases are characterized by the t(X;18)(p11.2;q11.2) translocation, which results mainly in the formation of oncogenic SS18-SSX1 or SS18-SSX2 fusions. In a typical SS18-SSX fusion transcript, exon 10 of SS18 is fused to exon 6 of SSX1/2. However, several variant fusion transcripts have been already described. In the present study, we examined the fusion transcript type in a series of 40 primary untreated SS tumor specimens using reverse transcription polymerase chain reaction and fluorescence in situ hybridization assay. We detected SS18-SSX1 transcript in 22 (55 %) patients and SS18-SSX2 transcript in 17 (42.5 %) patients, while in one patient, none of SS18-SSX1/2 fusion transcripts were identified. Among the cases under study, two tumors carried novel SS18-SSX1 and SS18-SSX2 variant translocations that were allegedly created by an alternative splicing, and in additional case, an unusual translocation variant previously described by other group was found. Our data suggest that alternative splicing may play an important role in novel fusion transcript formation, and additionally we show that it may be a recurrent event in SS. Furthermore, we describe the first case of a complex rearrangement possibly linking SS to REPS2 gene.Keywords
This publication has 36 references indexed in Scilit:
- Prognostic implication of SYT–SSX fusion type and clinicopathological parameters for tumor‐related death, recurrence, and metastasis in synovial sarcomaCancer Science, 2009
- The central proline rich region of POB1/REPS2 plays a regulatory role in epidermal growth factor receptor endocytosis by binding to 14-3-3 and SH3 domain-containing proteinsBMC Biochemistry, 2008
- Molecular characterization of a novel variant of a SYT–SSX1 fusion transcript in synovial sarcomaHistopathology, 2007
- A novel FISH assay for SS18–SSX fusion type in synovial sarcomaLaboratory Investigation, 2004
- REPS2/POB1 is downregulated during human prostate cancer progression and inhibits growth factor signalling in prostate cancer cellsOncogene, 2003
- A novel fusion gene, SS18L1/SSX1, in synovial sarcomaGenes, Chromosomes and Cancer, 2003
- t(X;18) Reverse Transcriptase-Polymerase Chain Reaction Demonstrating a Variant TranscriptThe Journal of Molecular Diagnostics, 2002
- Clinical impact of molecular and cytogenetic findings in synovial sarcomaGenes, Chromosomes and Cancer, 2001
- Association of SYT-SSX Fusion Types with Proliferative Activity and Prognosis in Synovial SarcomaLaboratory Investigation, 2000
- SYT–SSXGene Fusion as a Determinant of Morphology and Prognosis in Synovial SarcomaNew England Journal of Medicine, 1998